Add Notes

House Concurrent Resolution 1012
Representatives Rhoden, Abdallah, Bartling, Begalka, Bradford, Broderick, Burg, Davis, Duenwald, Duniphan, Elliott, Flowers, Frost, Fryslie, Garnos, Gillespie, Glenski, Hansen (Tom), Hanson (Gary), Hargens, Heineman, Hennies (Don), Holbeck, Hundstad, Hunhoff, Jaspers, Jensen, Juhnke, Klaudt, Kloucek, Koistinen, Kooistra, Lange, Lintz, Madsen, McCaulley, McCoy, Monroe, Napoli, Pederson (Gordon), Peterson (Bill), Peterson (Jim), Pummel, Sebert, Sigdestad, Slaughter, Smidt, Solum, Sutton (Duane), Teupel, Van Etten, Van Gerpen, Van Norman, and Wick and Senators Diedrich (Larry), Albers, Apa, Bogue, Brown (Arnold), Daugaard, Diedtrich (Elmer), Drake, Greenfield, Ham, Hutmacher, Kleven, Koetzle, Koskan, Madden, McCracken, Moore, Munson, Olson (Ed), Putnam, Reedy, Staggers, Sutton (Dan), Symens, and Vitter
Urging a reconsideration of the Food and Drug Administration's approval of mifepristone (RU-486), an investigation into the process followed in approving this drug, and a reassessment of the drug's safety.
Subject Index: House Concurrent Resolutions
Date
Action
Audio Debate Available
01/29/2002 House of Representatives Introduced and referred to House H.J. 340
01/30/2002 House of Representatives Adopt Resolution Passed, YEAS 54, NAYS 15. H.J. 355 Audio Available
01/31/2002 Senate Introduced and referred to Senate Health and Human Services S.J. 303
02/04/2002 Scheduled for committee hearing on this date
02/04/2002 Health and Human Services Concur in Resolution Passed, YEAS 6, NAYS 1. S.J. 349 Audio Available
02/05/2002 Senate Concur in Resolution Passed, YEAS 33, NAYS 1. S.J. 379

Bill Text Versions
Date
HTML Version
Acrobat Version
01/29/2002 As Introduced As Introduced
02/06/2002 Enrolled Enrolled


2002 Session Menu